The E2A proteins are basic helix-loop-helix transcription factors that regulate proliferation and differentiation in many cell types. In muscle cells, the E2A proteins form heterodimers with muscle regulatory factors such as MyoD, which then bind to DNA and regulate the transcription of target genes essential for muscle differentiation. We now demonstrate that E2A proteins are primarily localized in the nucleus in both C2C12 myoblasts and myotubes, and are degraded by the ubiquitin proteasome system evidenced by stabilization following treatment with the proteasome inhibitor, MG132. During the differentiation from myoblast to myotube, the cellular abundance of E2A proteins is relatively unaltered, despite significant changes (each B5-fold) in the relative rates of protein synthesis and protein degradation via the ubiquitin-proteasome system. The rate of ubiquitin-proteasome-mediated E2A protein degradation depends on the myogenic differentiation state (t½B2 h in proliferating myoblasts versus t½>10 h in differentiated myotubes), and is also associated with cell cycle in non-muscle cells. Our findings reveal an important role for both translational and post-translational regulatory mechanisms in mediating the complex program of muscle differentiation determined by the E2A proteins.
Introduction
The E2A proteins (i.e. E12 and E47, the two splice variants encoded by the E2A gene) (Sun and Baltimore, 1991) are members of the basic helix-loop-helix (bHLH) protein family of transcription factors involved in cell proliferation, differentiation and development. Their bHLH domain mediates protein dimerization through the HLH motif and E-box DNA binding through an adjacent basic region. These ubiquitous E2A proteins form active heterodimers with tissuespecific bHLH proteins, which then bind to DNA and activate the transcription of target genes. Tissue-specific bHLH proteins associated with E2A proteins include the MyoD family involved in skeletal muscle differentiation (Weintraub, 1993) , the achaete-scute family involved in neuronal differentiation (Guillemot et al., 1993) , and SCL/TAL which is involved in hematopoiesis (Hsu et al., 1991) . The E2A proteins are also required for lymphocyte development, and have also been implicated in cell growth, apoptosis and lymphomagenesis (Bain et al., 1994; Peverali et al., 1994; Yan et al., 1997; Quong et al., 2002; Lazorchak et al., 2005) .
During muscle differentiation, E2A proteins form heterodimers with MyoD, facilitate binding to E boxes in the promoter regions of muscle-restricted target genes and activate MyoD transcription activity (Lassar et al., 1991) . The E2A proteins are regulated by the dominantnegative Id (inhibitor of differentiation/DNA binding) proteins, which are HLH proteins that lack a basic, DNA-binding domain and function by sequestering E2A proteins through heterodimerization into an inactive state unable to bind DNA. The formation of the transcriptionally active complex between E2A proteins and MyoD is regulated by Id1, which is the most active Id protein in terms of MyoD binding (Langlands et al., 1997) .
Previously we demonstrated that the abundance of MyoD and Id1 are highly regulated with different mechanisms governing protein synthesis and degradation during muscle differentiation (Sun et al., 2005) . Further, in non-muscle cells E12 and E47 modulate cellular localization and proteasome-mediated degradation of MyoD and Id1 (Lingbeck et al., 2005) . Thus, the regulation of E2A protein level is important for muscle differentiation, yet remains largely unknown.
The E2A gene is expressed constitutively, in all tissues, with little developmental regulation (Roberts et al., 1993) , and the resultant protein levels are regulated mainly via post-transcriptional mechanisms, including via protein degradation by the ubiquitin-proteasome system. The pathway involves the activation of ubiquitin by the ubiquitin-activating enzyme, E1, followed by transfer of ubiquitin to E2, ubiquitin-conjugating enzyme. E2 shuttles the ubiquitin to the substratespecific ubiquitin ligase, E3, which then delivers the ubiquitin to the protein substrate to be degraded by the 26s proteasome. Previous studies have shown that the E2A proteins are degraded by the ubiquitinproteasome system through the ubiquitin-conjugating enzyme, UbcE2A (mUbc9) (Kho et al., 1997; Huggins et al., 1999) . As little is known about the regulation and degradation of E2A proteins during muscle differentiation, we sought to determine whether regulation of E2A proteins occurs and whether modulation of protein synthesis or degradation governs the abundance of this key factor.
Using C2C12 cells, we show here that E2A proteins are primarily localized in the nucleus in both myoblasts and myotubes, and appear to be degraded by the ubiquitin proteasome system as the proteasome inhibitor, MG132, stabilized the presence of both E12 and E47. The rate of ubiquitin-proteasome-mediated E2A protein degradation is stage-dependent during muscle differentiation, with t½B2 h in proliferating myoblasts compared to t½>10 h in differentiated myotubes. The significantly decreased protein degradation rate in myotubes, combined with an induction in protein synthesis rate of E2A, kept the cellular abundance of E2A proteins relatively stable during the differentiation from myoblast to myotube. The E2A proteins are also stabilized in G0 growth-arrested Hela cells compared to that seen in proliferating cells. These results taken together with our previous study of MyoD and Id1 (Sun et al., 2005) support an important role for the ubiquitinproteasome pathway in E2A protein regulation during muscle development.
Results
To study E2A protein degradation and its regulation during muscle differentiation, we first examined the locus of the E2A proteins in C2C12 myoblasts and myotubes. Indirect immunofluorescent examination revealed that the E2A proteins are localized to the nucleus in both C2C12 myoblasts and myotubes. In addition, myotubes express E2A protein in the cytoplasm (Figure 1a ). It should be noted that the E2A proteins here represent both endogenous E12 and E47. We performed control experiments to test the crossactivity for E12 or for E47 with several commercially available antibodies, and found that no available antibody reacts exclusively with E12 or E47 (data not shown). The immunofluorescent signals shown here for the endogenous E2A proteins were verified by blocking experiments using the peptide, which was initially used to generate the antibody used in this study (data not shown).
We next determined E2A protein expression during the time course of C2C12 myogenic differentiation by immunoblotting. Cellular abundance of the E2A proteins is relatively stable when compared to that of b-actin and cyclin-dependent kinase 4 (cdk4) during the differentiation from myoblast (D-1, 1 day before the addition of the differentiation medium (DM)) to myotube (D6, 6 days after the addition of the DM) ( Figure 1b) . As a control, the abundance of the contractile protein myosin heavy chain was also determined using the same cell lysates and showed a progressive accumulation from the initiation of the differentiation (D0) onward (Figure 1b) . Proliferating C2C12 myoblasts at 70-80% confluency (D-1) in GM were grown to reach confluency, switched to DM (D0), and then maintained in DM for up to 6 days (D1-D6) with fresh media changed every 24 h. Cells were harvested, lysed and were evaluated via SDS-PAGE and Western blot for E2A proteins, actin, cdk4 and myosin heavy chain. Equal amounts of total protein were loaded for each lysate. The pixels for each band were measured and normalized so that the number of pixels at D0 was 1. The ratios of the numbers of pixels for each band between E2A protein and b-actin, and E2A protein and cdk4 were plotted versus time to show the relative change of E2A protein abundance during the course of C2C12 myogenic differentiation.
To determine whether the two splice variants of the E2A proteins, E12 and E47, are degraded by the ubiquitin-proteasome system in muscle cells, we overexpressed E12 and E47 in C2C12 myoblasts, and determined their degradation half-lives. To allow discrimination from the endogenous E2A proteins during immunoblotting, we attached a Myc tag to the C-terminus of E12 and an HA tag to the E47 Cterminus, respectively. As shown in Figure 2 , both E12 and E47 are rapidly degraded in C2C12 myoblasts with a half-life of about 2 h. Incubation of cells with MG132, a potent and selective inhibitor of the proteasome, markedly stabilized the presence of both E12 and E47, suggesting that the ubiquitin-proteasome system is responsible for their degradation in muscle cells.
Muscle differentiation from single nucleated myoblasts to syncytial myotubes is a process involving many morphological and biochemical changes. To determine how the muscle differentiation state affects the degradation of the E2A proteins during differentiation, we determined the half-lives of endogenous E2A proteins at different stages of C2C12 myogenic differentiation, from myoblast (D-1) to the initiation of differentiation (D0, cells reach confluency and DM is added) and at 2, 4 and 6 days into the differentiation (D2, D4 and D6). As seen in Figure 3 , the rate of ubiquitin-proteasome-mediated E2A protein degradation is dependent on the muscle differentiation state, with t½B2 h in myoblasts versus t½>10 h in differentiated myotubes. Although the precise nature of the E2A doublet on immunoblots is unknown (see below), the specificity of these double bands was confirmed by control blocking experiments using the peptide that was used to generate the antibody used herein (data not shown).
The observed changes in E2A protein stability suggest that the protein abundance may be regulated posttranslationally via the ubiquitin system during muscle differentiation. However, a significant decrease in E2A protein degradation rate alone could not explain the previous observation that E2A protein content was kept relatively stable during the course of muscle C2C12 myoblasts transiently transfected with E12-myc or E47-HA encoding DNA were treated with CHX, or CHX plus MG132 after transfection. Cells were harvested, lysed at 0, 0.5, 1, 2 and 3 h and were evaluated via SDS-PAGE and Western blot for E12-myc or E47-HA. An equal volume of each lysate was loaded onto the gel. The pixels for each band were measured and normalized so that the number of pixels at t ¼ 0 was 100%. The log 10 of the percent of pixels was plotted versus time and the t½ was calculated from the log 10 of 50%. 
To gain further insight into other potential regulatory mechanisms during differentiation, we compared E2A protein synthesis rates and their mRNA levels in myoblasts versus in myotubes. We have previously shown that under the experimental conditions in which E2A protein degradation is abolished, the relative rate of E2A protein accumulation correlates with the relative rate of protein synthesis in vivo (Sun et al., 2005) . As shown in Figure 4a , E2A protein accumulated to a greater degree in myoblasts than in myotubes, thus suggesting that the E2A protein synthesis rate is faster in myoblasts than in myotubes. In contrast, E2A mRNA level was unchanged between myoblast and myotube ( Figure 4b ), suggesting that there is no or little transcriptional regulation for the E2A proteins during muscle differentiation.
The marked differences in E2A protein half-life between myoblast and myotube is not dissimilar in magnitude from the various half-lives reports for E12 and E47 in non-muscle cells (Deed et al., 1996; Kho et al., 1997; Lingbeck et al., 2005) . For example, others have reported a 1-h half-life for E12 and E47 in COS7 and NIH3T3 cells (Kho et al., 1997) , a 5-6 h half-life for E12 and E47 in Hela cells (Lingbeck et al., 2005) , and a 24-h half life for E47 in COS7 cells (Deed et al., 1996) . As cells exit the cell cycle upon initiation of muscle differentiation, and overexpression of E12 or E47 inhibits cell proliferation, we asked whether the stabilization of E2A proteins was associated with cell cycle arrest, rather than being specific to muscle differentiation. To test this possibility, we examined the half-life of E2A proteins in Hela cells under a variety of growth conditions. As shown in Figure 5 , both endogenous E2A proteins and overexpressed E47-HA are degraded rapidly in proliferating Hela cells, with similar half-lives of about 2 h. However, E2A proteins were greatly stabilized in G0 growth-arrested Hela cells, with halflives longer than 10 h. These results suggest that the E2A protein level may be regulated post-translationally dependent upon the cell cycle. To verify that E2A protein stabilization in G0 growth-arrested cells is not due to a generalized decrease in protein degradation, we also determined the half-life of CCAAT/enhancerbinding protein d (C/EBPd). As shown in Figure 5 , the rate of C/EBPd degradation, which is ubiquitin-proteasome dependent (Dearth and DeWille, 2003) , is not decreased in G0 growth-arrested Hela cells (i.e. t½B 3-4 h in proliferating and G0 growth-arrested cells).
We also noted the presence of two bands for E2A proteins in C2C12 cells in our Western blots. Both Relative E2A protein synthesis rate and semiquantitative RT-PCR of E2A in myoblasts and myotubes. For protein synthesis, C2C12 myoblasts (m) and myotubes (D6) (') were treated with MG132. Cells were lysed at 0, 0.5, 1, 1.5 and 2 h and were evaluated via SDS-PAGE and Western blot for E2A proteins. An equal volume of each lysate was loaded onto the gel. The pixels for each band were measured and normalized so that the number of pixels at t ¼ 0 was 1. The pixels of each band were plotted versus time. For RT-PCR, total RNA samples were extracted from C2C12 myoblasts and myotubes. The pixels for each band were measured and plotted for comparison of E2A mRNA levels in myoblasts and myotubes. RT-PCR for GAPDH was also performed with the same samples as a control for the amount of reverse-transcribed cDNA present in the samples. E2A protein degradation in muscle differentiation L Sun et al bands appear to be phosphorylated E2A proteins as both collapse upon protein phosphatase treatment (Figure 6a ). The protein degradation kinetics appear to apply to both bands, as in myoblasts, both bands appear degraded over time, and each is stabilized in myotubes. As protein phosphorylation often serves as an intermediate for degradation by the ubiquitinproteasome system, we also asked what the relationship could be between the E2A protein phosphorylation and degradation in muscle cells. It has been shown that mitogen-activated protein (MAP) kinase-mediated phosphorylation is necessary but not sufficient for Notch-induced E47 degradation in B and T cells (Nie et al., 2003) . Here in C2C12 myoblasts, no stabilization of endogenous E2A proteins was observed after cell treatment using MAP kinase inhibitors, which inhibit the Ras-MEK-Erk pathway and the p38 pathway (data not shown). Therefore, we constructed the E47(S346A-T349AS353A)HA mutant, which abolishes the MAP kinase sites crucial for Notch-induced protein degradation in B and T cells (Nie et al., 2003) . As shown in Figure 6 , the protein stability of the E47(S346AT349A-S353A)HA mutant did not change when compared to that of wild-type E47. In addition, serine 133 of E47 has been indicated to be an important regulatory site for p38
MAP kinase-induced MyoD and E47 heterodimerization and muscle-specific gene transcription (Lluis et al., 2005) . However, the evaluation of E47S133AHA stability revealed no correlation between Ser133 phosphorylation and E47 degradation.
To gain further insights, we also constructed deletion mutants of E47-HA based on the known functional domains of the wild-type protein (Voronova and Baltimore, 1990; Aronheim et al., 1993; Huggins et al., 1999) . E47(319-645)HA is the deletion mutant missing the transcriptional activation domain I (ADI), E47(470-645)HA is the deletion mutant missing both ADI and ADII, whereas E47(508-645)HA is the deletion mutant missing both ADI and ADII, and the mUBC9-binding site. Protein stability analysis showed that only E47(508-645)HA protein is stabilized compared to wild-type E47 (Figure 6b ) as we expected, as the mUBC binding site is essential for the function of ubiquitin-conjugating enzyme E2 during E47 protein ubiquitination and degradation (Huggins et al., 1999) . The unaltered stability of E47(319-645)HA and E47(470-645) compared to that of wild-type E47 suggests that E47 protein degradation is likely not associated with phosphorylation outside the bHLH domain (amino acids 508-645). The examination of amino acids 508-645 of the E47 protein did not reveal any MAP kinase phosphorylation site. Taken together, our results suggest that E47 phosphorylation by MAP kinase appears not to be associated with its degradation mediated by the ubiquitin system.
Discussion
The E2A proteins are class I bHLH proteins and are involved in a large variety of developmental processes, characterized by their broad tissue distribution and by their ability to form homodimers or heterodimers with tissue restricted class II bHLH transcription factors. Turnover of the E2A proteins is governed by the ubiquitin-proteasome pathway. Previous studies, mostly focused on E2A protein regulation and degradation during B-cell development, have suggested that ubiquitin-proteasome mediated E2A protein degradation is one of the important mechanisms involved in the regulation of their cellular abundance and biological activities (Nie et al., 2003; Van der Put et al., 2004; Riley et al., 2005) . However, little information is available regarding the regulation and degradation of the E2A proteins during muscle differentiation.
Here, we show that the E2A proteins are kept at a relatively stable level when compared to b-actin and cdk4 during C2C12 myogenic differentiation (Figure 1b ). The unaltered E2A protein level during differentiation from myoblasts to myotubes is likely controlled post-transcriptionally, as there was no change in the E2A mRNA level in myoblasts versus myotubes (Figure 4b ). We further show that, during differentiation, the rates of E2A protein degradation and synthesis (Figures 3 and 4a) both decreased (B5-fold). This 
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suggests that E2A protein levels during muscle differentiation are governed by the combination of altered E2A protein synthesis and degradation rates. The marked decrease in the E2A protein degradation rate in differentiating C2C12 cells (t½>10 h in myotubes versus t½-2 h in myoblasts) suggests that the ubiquitinproteasome system is important for preserving E2A, which is crucial for the transcriptional activation of muscle regulatory factors during muscle differentiation. Stabilization of E2A protein degradation rate took place concurrent with the C2C12 cells commitment to terminal differentiation. This suggests that the E2A proteins may be relatively spared whereas forming active transcriptional complexes with muscle regulatory factors during the initiation and maintenance of muscle differentiation. Previous electrophoresis mobility shift analyses have shown that E2A/MyoD/Ebox-DNA complexes only form after the initiation of muscle differentiation (Lluis et al., 2005) . In proliferating myoblasts, rapid turnover of the E2A proteins may prevent the cells from the commitment for differentiation.
The mechanisms underlying this apparent stabilization of E2A protein degradation during muscle differentiation remain unclear. There are at least two possibilities to consider. The E2A proteins may be stabilized via heterodimerization with their binding partners, as studies in Hela cells have shown that both MyoD and Id1 are able to decrease the degradation rates of E12 and E47 upon heterodimerization (Lingbeck et al., 2005) . Alternatively, the stabilization of E2A protein degradation may be associated with the expression and activity of components involved in the ubiquitin-proteasome pathway responsible for E2A protein degradation, such as the ubiquitin-conjugating enzymes or ubiquitin ligases that are yet to be identified.
The decreased degradation rate seen in E2A proteins is not a 'global' phenomenon during muscle differentiation. Previous studies have shown that protein degradation may be regulated via different mechanisms by the ubiquitin system. For example, during myogenic differentiation of C2C12 cells, the degradation rate of extracellular signal-regulated kinase 3 by the ubiquitin system is decreased in a similar fashion to that of the E2A proteins (Coulombe et al., 2003) ; whereas the 6-phosphofructo-2-kinase undergoes enhanced protein degradation via the ubiquitin-proteasome pathway (Riera et al., 2003) . In addition, our recent study of MyoD and Id1 in differentiating C2C12 cells revealed no alteration in the rates of degradation of either protein (Sun et al., 2005) .
During muscle differentiation, the cellular localization of E2A proteins is also of significance, as E2A proteins exert their regulatory functions by heterodimerization with muscle regulatory factors and Id proteins. E2A proteins promote the transcriptional activity of MyoD by recruiting it to DNA regulatory sites in heterodimeric DNA complexes that form in preference to either homodimeric complex. E2A proteins also form heterodimers with Id1 with higher affinity; therefore E2A may be trapped by Id1 and thus not able to form DNAbinding active complexes with MyoD. We show here that the E2A proteins are localized in the nucleus in myoblasts (Figure 1a) . This supports the notion that E2A proteins can heterodimerize with MyoD or Id1, which are also localized to the nucleus in myoblasts (Sun et al., 2005) . In myotubes, however, the nuclear localization of the E2A proteins suggests that in the nucleus they form heterodimers primarily with MyoD, but not with Id1, as only MyoD is localized in the myotube in the nucleus, whereas Id1 is localized exclusively to the cytoplasm (Sun et al., 2005) . In myotubes, the physical separation of nuclear MyoD and E2A proteins from Id1 (perhaps together with cytoplasmic E2A) is consistent with the concept that heterodimers of MyoD and E2A are the active transcriptional complex responsible for the initiation and maintenance of muscle differentiation.
We further show that E2A protein degradation rates are diminished not only in differentiated muscle cells but also in G0 growth-arrested Hela cells ( Figure 5 ). Hence, we hypothesize that the E2A proteins are stabilized upon G0 cell cycle arrest. To verify that the stabilization of the E2A proteins is not the result of a global decrease in protein degradation rates in G0 cells, we show that degradation of C/EBPd, which is ubiquitin-dependent (Dearth and DeWille, 2003) , is not decreased in G0 growth-arrested Hela cells ( Figure 5 ). Our results with C/EBPd degradation are also consistent with the observation that C/EBPd exhibits a half-life of about 2 h in G0 growth-arrested mouse mammary epithelial cells (Dearth and DeWille, 2003) . Our observations regarding marked differences in E2A degradation rate (i.e. in half-life) dependent upon the cell cycle state place earlier disparate results in perspective (e.g. Kho et al. (1997) reported a t½B1 h for E12 in COS7 cells, whereas a t½B18 h was reported for E12 in COS7 cells by Deed et al. (1996) , using similar methodology).
Our Western blots show the presence of two bands for E2A proteins in C2C12 cells. Both bands appear to be phosphorylated E2A proteins as both collapse upon protein phosphatase treatment (Figure 6a ). Protein phosphorylation often serves as an intermediate for degradation by the ubiquitin-proteasome system. The relationship between E2A protein phosphorylation and degradation in muscle cells remains unknown. In B cells, it has been shown that MAP kinase-mediated phosphorylation is necessary but not sufficient for Notchinduced E47 degradation (Nie et al., 2003) . Treatment of the transfected NIH3T3 cells with a MAP kinase inhibitor stabilized E47 protein in the presence of Notch and MEK1. However, we did not detect stabilization of E2A proteins following MAP kinase inhibitor treatment of C2C12 cells (data not shown). Furthermore, assessment of the turnover of E47 phosphorylation site mutants also failed to provide any link between E47 phosphorylation and degradation (Figure 6b ). Thus, in muscle cells, E2A protein phosphorylation may not relate to its degradation by the ubiquitin system, but likely relates to other aspects of function such as protein complex formation, as E47 phosphorylation by p38 MAP kinase promotes MyoD/E47 association and E2A protein degradation in muscle differentiation L Sun et al muscle-specific gene transcription (Lluis et al., 2005) . It may be important to note here that whereas in muscle cells, MyoD/E47 heterodimer is the active transcription regulator that binds DNA, E47 forms DNA-binding homodimers in B cells. Therefore, it is reasonable to expect that E47 protein phosphorylation by MAP kinase pathway regulates its transcription activity by different mechanisms, namely through mediating E47 protein degradation and protein abundance in B cells, but through mediating its heterodimerization with tissue-specific MyoD in muscle cells. Taken together, our findings reveal an important role for both protein degradation via the ubiquitin-proteasome pathway and protein synthesis in mediating the complex program of muscle differentiation determined by the E2A proteins. These results, together with those of MyoD and Id1 (Sun et al., 2005) , suggest that cellular abundance of these specific protein species is highly regulated by distinct mechanisms or combinations thereof.
Material and methods
Plasmids and construction of E12-Myc, E47-HA and mutants Wild-type E12 and E47 in pCIneo have been described previously (Lingbeck et al., 2005) . E47 with a 1 Â HA tag at the C-terminus and E12 with a C-terminus 1 Â Myc tag were constructed by insertion of the HA tag or the Myc tag into pCIneo harboring wild-type E47 or E12 encoding DNA. E47-HA truncation mutants (E47(319-645)HA, E47(470-645)HA and E47(508-645)HA) were constructed by insertion of the desired E47 DNA fragments into pCIneo. E47 point mutation mutants were constructed using Stratagene's QuikChange. site-directed mutagenesis kit. Polymerase chain reaction primers were purchased from IDT. DNA sequencing using Big Dye Version 3.1 (ABI Biosystems, Foster City, CA, USA) was used to confirm all sequences.
Cell culture
The C2C12 mouse myoblast cell line was obtained from the American Type Culture collection. The cells were routinely propagated in growth medium (GM), Dulbecco's modified Eagle's medium (DMEM) (Sigma, St Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin G and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA), and maintained in a humidified chamber at 371C with 5% CO 2 . Myogenic differentiation was induced by changing the growth medium to DM, DMEM supplemented with 2% horse serum (HyClone, Logan, UT, USA), 100 U/ml penicillin G and 100 mg/ml streptomycin, when cells reach confluency. Cells were then maintained in DM for 6 days with the medium being changed every 24 h. Transient transfections of C2C12 myoblasts were performed using the Fugene 6 reagent (Roche Molecular Biochemicals, Indianapolis, IN, USA) according to the manufacturer's instructions.
Hela cells were obtained from the tissue culture support center of Washington University, School of Medicine. The cells were routinely propagated in DMEM (Sigma) supplemented with 10% FBS, 100 U/ml penicillin G and 100 mg/ml streptomycin (Invitrogen), and maintained in a humidified chamber at 371C with 5% CO 2 . For G0 growth arrest, Hela cells were grown to 100% confluency, washed with serum-free media, and starved in growth arrest media (DMEM supplemented with 0.02% FBS) for 24 h.
Immunofluorescence C2C12 cells on glass cover slips were first washed with PBSc, a phosphate-buffered saline solution (PBSa, Fisher Biotech, Pittsburgh, PA, USA) supplemented with 100 mM CaCl 2 and 50 mM MgCl 2 , fixed in 4% paraformaldehyde, quenched in 0.1 M ethanolamine (pH 8.0) and permeabilized in 1% Triton X-100 (Sigma). Subcellular localization of E2A proteins in C2C12 myoblasts or myotubes was then determined by indirect immunofluorescence using the rabbit polyclonal antibodies (anti-E2A Á E12 (V-18), Santa Cruz Biotechnology, Santa Cruz, CA, USA) followed by incubation with Alexa Fluor 568 goat anti-rabbit IgG (heavy and light chains) (Molecular Probes, Carlsbad, CA, USA) after blocking the cells in PBSc containing 1% bovine serum albumin and 0.01% TW-80. Cells were observed using a Zeiss Axioskop microscope, and images were taken using a Zeiss AxioCam digital camera. Blocking control experiments for the detection of E2A proteins were performed by preincubating the probing primary antibody with the corresponding peptides (E2A Á E12 (V-18)P, Santa Cruz Biotechnology), which were initially used to generate the antibodies.
Protein expression level during myogenic differentiation C2C12 cells were washed with PBSa twice on ice and harvested at different stages of myogenic differentiation (D-1: 70-80% confluent C2C12 myoblasts in GM, D0: 100% confluent C2C12 cells and the time point for switching the medium to DM, D1-D6: C2C12 cells cultured in DM for 1-6 days). All cells were lysed for at least 30 min in PBSa containing 0.5% Igepal, 1 mM dithiothreitol, 1 mM pepstatin, 2.5 mg/ml leupeptin and 0.2 mM phenylmethylsulfonyl fluoride. The collected cells were then been sonicated briefly and centrifuged at 14 000 r.p.m. for 10 min at 41C to remove cellular debris. Protein concentration of each freshly prepared cell lysate was determined by the Bradford assay (Bio-Rad, Hercules, CA, USA). After mixing with an equal volume of 2 Â Laemmli sample buffer (Bio-Rad), cell lysates containing equal amounts of total protein were loaded in each lane, resolved by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membrane (Osmonics, Minnetonka, MN, USA). Membranes were probed with primary antibodies (rabbit polyclonal antibodies anti-E2A Á E12 (V-18), antimyosin heavy chain (H-300) and anti cdk4, Santa Cruz Biotechnology; and mouse monoclonal antibody for b-actin, Sigma) followed by incubation with a secondary horseradish peroxidase-conjugated antibody. Protein bands were detected by chemiluminescence (Amersham Biosciences, Buckinghamshire, UK). Blocking control experiments for E2A Western blot were performed by pre-incubating the probing primary antibody with peptide (E2A Á E12 (V-18)P, Santa Cruz Biotechnology) before applying to the membrane.
Determination of protein degradation half-life C2C12 cells were incubated with cycloheximide (CHX 100 mg/ml, Sigma) to inhibit further protein synthesis. The proteasome inhibitor MG132 (N-benzyloxycarbonayl-leu-leu-leucinal, 20 mM, International Peptides, Louisville, KY, USA) was added along with CHX when necessary. Following incubation for 0, 0.5, 1, 2 and 3 h, cells were harvested, lysed and cell lysates were collected as described above. After treatment with Laemmli sample buffer (Bio-Rad), equal volumes of each sample were loaded in each lane for gel electrophoresis. Western blotting was performed in the same fashion as described above. A mouse monoclonal anti-HA antibody (Covance, Princeton, NJ, USA) was used for the detection of E47-HA and all E47 mutants, whereas a mouse monoclonal anti-Myc tag antibody (Upstate, Temecula, CA, USA) was used for the detection of E12-myc protein. Desired protein bands from the Western blottings were quantitated using the EDAS system (Eastman Kodak Co., Rochester, NY, USA), and the data were graphed using the Excel graphing program (Microsoft). Protein degradation rate is expressed as half-life (t½), the time for degradation of 50% of the protein. The Western blot analyses are within a linear range and each of the half-life data reported was evaluated by 3-6 independent determinations and is expressed as mean7s.d.
Comparison of protein synthesis rate C2C12 cells were incubated with MG132 (20 mM). Following incubation for 0, 0.5, 1, 1.5 and 2 h, cells were harvested, lysed, and cell lysates were collected as described above. After treatment with Laemmli sample buffer (Bio-Rad), equal volumes of each sample were loaded in each lane for gel electrophoresis. Western blottings were performed in the same fashion as described above. The pixels for each band were measured and normalized so that the number of pixels at t ¼ 0 was 1. The pixels of each band were plotted versus time.
Protein synthesis rates were compared based on the initial slope from plots of data for the first hour.
RNA isolation and reverse transcription-polymerase chain reaction Total RNA samples from C2C12 myoblasts and differentiated myotubes were obtained using RNAZol reagents (Tel-test, Inc.) . following the manufacturer's instructions. Reverse transcription-polymerase chain reaction (RT-PCR) was performed for E2A and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using ProSTAR RT-PCR system (Stratagene, La Jolla, CA, USA). The quantitative analyses of RT-PCR are within a linear range and are performed by using Kodak EDAS system. The E2A primers are as follows: 5 0 -TACCCCTCCGCCAAGACC-3 0 , and 5 0 -TTGGGGGATAA GGCACTG-3 0 (with a product of 535 base pairs).
